Real‑World Studies Outshine Single‑Arm Trials for Cancer Survival
Experts from European oncology societies and regulatory bodies compared different study designs to see which gives the strongest evidence that a new cancer drug truly improves survival. They used a method called conjoint analysis to score how convincing each study type was under various conditions,